van Harten A, Jongbloed W, Teunissen C, Scheltens P, Veerhuis R, van der Flier W. CSF ApoE predicts clinical progression in nondemented APOE?4 carriers. Neurobiol Aging. 2017;57:186-194 pubmed publisher

Bissig Choisat B, Wang L, Legras X, Saha P, Chen L, Bell P, et al. Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model. Nat Commun. 2015;6:7339 pubmed publisher

Bankwitz D, Vieyres G, Hueging K, Bitzegeio J, Doepke M, Chhatwal P, et al. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins. J Virol. 2014;88:12644-55 pubmed publisher

Handattu S, Nayyar G, Garber D, Palgunachari M, Monroe C, Keenum T, et al. Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice. Atherosclerosis. 2013;227:58-64 pubmed publisher

Morales D, Acevedo S, Skolasky R, Hechavarría R, Santiago S, de la Torre T, et al. Translational spatial task and its relationship to HIV-associated neurocognitive disorders and apolipoprotein E in HIV-seropositive women. J Neurovirol. 2012;18:488-502 pubmed publisher

Liu M, Kuhel D, Shen L, Hui D, Woods S. Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice. Am J Physiol Regul Integr Comp Physiol. 2012;303:R903-8 pubmed publisher